Company Analysis Outset Medical, Inc.
1. Summary
Advantages
- The stock's return over the last year (430.45%) is higher than the sector average (-37.79%).
Disadvantages
- Price (11.67 $) is higher than fair price (5.69 $)
- Dividends (0%) are below the sector average (0.5448%).
- Current debt level 41.97% has increased over 5 years from 32.92%.
- The company's current efficiency (ROE=-140.62%) is lower than the sector average (ROE=9.48%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Outset Medical, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 41% | -23.2% | 1% |
| 90 days | 932.7% | -36.6% | -8.6% |
| 1 year | 430.5% | -37.8% | 9.1% |
OM vs Sector: Outset Medical, Inc. has outperformed the "Healthcare" sector by 468.24% over the past year.
OM vs Market: Outset Medical, Inc. has outperformed the market by 421.36% over the past year.
Highly volatile price: OM is significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical deviations of more than +/- 15% per week.
Long period: OM with weekly volatility of 8.28% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (11.67 $) is higher than the fair price (5.69 $).
Price is higher than fair: The current price (11.67 $) is 51.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (57.21).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (48.7).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.28) is lower than that of the sector as a whole (4.65).
P/BV vs Market: The company's P/BV (2.28) is lower than that of the market as a whole (3.42).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (7.61) is lower than that of the sector as a whole (33.44).
P/S vs Market: The company's P/S indicator (7.61) is lower than that of the market as a whole (10.24).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-2.26) is higher than that of the sector as a whole (-17.68).
EV/Ebitda vs Market: The company's EV/Ebitda (-2.26) is lower than that of the market as a whole (25.23).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 1.33% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (1.33%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (156.84%).
5.4. ROE
ROE vs Sector: The company's ROE (-140.62%) is lower than that of the sector as a whole (9.48%).
ROE vs Market: The company's ROE (-140.62%) is lower than that of the market as a whole (8.97%).
5.5. ROA
ROA vs Sector: The company's ROA (-55.07%) is lower than that of the sector as a whole (0.1068%).
ROA vs Market: The company's ROA (-55.07%) is lower than that of the market as a whole (6.31%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-37.93%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (-37.93%) is lower than that of the market as a whole (10.96%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5448%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
